Kaletra and Glycosuria - a phase IV clinical study of FDA data

Summary:

Glycosuria is reported as a side effect among people who take Kaletra (lopinavir; ritonavir), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Viread, and have Gastric ulcer.

The phase IV clinical study analyzes which people have Glycosuria when taking Kaletra. It is created by eHealthMe based on reports of 22,879 people who have side effects when taking Kaletra from the FDA, and is updated regularly.

What is Kaletra?

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. eHealthMe is studying from 23,070 Kaletra users. Check the latest studies of Kaletra.

What is Glycosuria?

Glycosuria (excretion of glucose into the urine) is found to be associated with 239 drugs and 343 conditions by eHealthMe. Check the latest studies of Glycosuria.

On Jul, 19, 2026

22,879 people reported to have side effects when taking Kaletra.
Among them, 71 people (0.31%) have Glycosuria.

Among these 71 people:

How long have people been on Kaletra when they have Glycosuria? *

What is the gender of people who have Glycosuria when taking Kaletra? *

female: 24.29 %
male: 75.71 %

What is the age of people who have Glycosuria when taking Kaletra? *

What are other drugs people take besides Kaletra? *

What are other side effects people have besides Glycosuria? *

Weight Decreased: 24 people, 33.80%
Acute Kidney Failure: 24 people, 33.80%
Abdominal Pain: 24 people, 33.80%
Back Pain: 22 people, 30.99%
Nausea (feeling of having an urge to vomit): 19 people, 26.76%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 18 people, 25.35%
Osteopenia (a condition where bone mineral density is lower than normal): 18 people, 25.35%
Headache (pain in head): 17 people, 23.94%
High Blood Cholesterol: 16 people, 22.54%
Anaemia (lack of blood): 16 people, 22.54%

What are the existing conditions these people have? *

Joint Pain: 2 people, 2.82%
Gastric Ulcer (stomach ulcer): 2 people, 2.82%
Rickets (softening of bones): 1 person, 1.41%
Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 1.41%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 1 person, 1.41%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 1.41%
Pain: 1 person, 1.41%
Lung Disorder (lung disease): 1 person, 1.41%
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 1 person, 1.41%
Hypertensive Nephropathy (hypertensive renal disease): 1 person, 1.41%

* Approximation only. Some reports may have incomplete information.

Do you take Kaletra and have Glycosuria?

- Check whether Glycosuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kaletra:

Kaletra (23,070 reports)

Glycosuria treatments and more:

Glycosuria (1,659 reports)

Browse all side effects of Kaletra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glycosuria:

Glycosuria (239 drugs)

Browse all the conditions that are associated with Glycosuria:

Glycosuria (343 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lopinavir; ritonavir (the active ingredients of Kaletra) and Kaletra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.